Maria Dall’Era is the Jean S. Engleman Distinguished Professor of Medicine and Chief of the Division of Rheumatology at the University of California, San Francisco (UCSF). She is the Director of the UCSF Rheumatology Clinical Research Center and Co-director of the UCSF Lupus Clinic.
Dr. Dall'Era received her undergraduate degree in Immunology from the University of California, Berkeley and completed her medical degree, residency in internal medicine, chief residency, and rheumatology fellowship at the University of California, San Francisco. She is a clinical researcher and practicing rheumatologist, specializing in systemic lupus erythematosus (SLE).

Dr. Dall'Era's scholarly activities focus on the development of novel therapies and the epidemiology and outcomes of people living with SLE and lupus nephritis. She is the PI of a CDC-funded population- based longitudinal lupus cohort in the San Francisco Bay Area called the California Lupus Epidemiology Study and the PI on clinical trials focused on SLE and lupus nephritis (LN).

She holds several international and national leadership positions including serving as Co-Chair of the Lupus Therapeutics Board of Directors, Co-Chair of the LRA's Lupus Industry Council, and member of the Lupus Accelerating Breakthroughs Consortium Research Committee. She is also a steering committee member of the Lupus Academy and Lupus Forum.
She serves as a member of the core leadership team overseeing the development of the American College of Rheumatology's Guidelines for the Treatment of SLE and LN.

She has authored numerous publications in the areas of SLE and lupus nephritis. She is a co-author of the Treatment of Lupus Nephritis chapters in Up-To-Date.

She has received several honors and awards for her work including the UCSF Exceptional Physician Award, the Ephraim Engleman Award for Arthritis Research, the Edmund L. Dubois Memorial Lectureship Award from the American College of Rheumatology, and the Evelyn V. Hess award from the Lupus Foundation of America.